Hess, U

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, Thomas; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone marrow transplantation, 52(4), pp. 650-652. Nature Publishing Group 10.1038/bmt.2016.339

Gössi, F; Spahn, Martin; Zweifel, Martin; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, Julian; Pabst, Thomas (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone marrow transplantation, 52(2), pp. 334-336. Nature Publishing Group 10.1038/bmt.2016.285

Miranda, M B; Lauseker, M; Kraus, M-P; Proetel, U; Hanfstein, B; Fabarius, A; Baerlocher, Gabriela M.; Heim, D; Hossfeld, D K; Kolb, H-J; Krause, S W; Nerl, C; Brümmendorf, T H; Verbeek, W; Fauser, A A; Prümmer, O; Neben, K; Hess, U; Mahlberg, R; Plöger, C; ... (2016). Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia, 30(6), pp. 1255-1262. Nature Publishing Group 10.1038/leu.2016.20

Passweg, J; Baldomero, H; Stern, M; Bargetzi, M; Ghielmini, M; Leibundgut, K; Duchosal, M; Hess, U; Seger, R; Buhrfeind, E; Schanz, U; Gratwohl, A (2010). Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect. Swiss medical weekly, 140(23-24), pp. 326-334. Muttenz: EMH Schweizerischer Ärzteverlag

Keller, P; Angelillo-Scherrer, A; Bargetzi, M; Goede, J; Hess, U; Imbach, P; Mach-Pascual, S; Mey U Rüfer, A; Schmidt, A (2010). Diagnose und Behandlung der primären Immun-Thrombozytopenie. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10(50), pp. 875-883. Basel: EMH Editores Medicorum Helveticorum

Taverna, C; Bargetzi, M; Betticher, D; Gmür, J; Gregor, M; Heim, D; Hess, U; Ketterer, N; Lerch, E; Matthes, T; Mey, U; Pabst, T; Renner, C (2010). Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations. Swiss medical weekly, 140, w13054. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2010.13054

Zenhäusern, R; Schmitz, S-F Hsu; Solenthaler, M; Heim, D; Meyer-Monard, S; Hess, U; Leoncini, L; Bargetzi, M; Rufener, B; Tobler, A (2009). Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leukemia & lymphoma, 50(9), pp. 1501-11. London: Informa Healthcare 10.1080/10428190903131755

Laurencet, F; Ballabeni, P; Rufener, B; Hess, U; Cerny, T; Fey, M; Luthi, JM; Plancherel, C; Zulian, GB; Swiss, Group for Clinical Research (SAKK) (2007). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica, 117(1), pp. 40-7. Basel: Karger 10.1159/000096787

Gratwohl, A; Heim, D; Bargetzi, M; Baerlocher, GM; Chalandon, Y; Duchosal, M; Gregor, M; Hess, U; Oppliger Leibundgut, E; Passweg, J; Schranz, U; Dirnhofer, S (2007). Behandlung der chronischen myeloischen Leukämie 2007. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(7), pp. 934-940. Basel: EMH Editores Medicorum Helveticorum